SMS Pharmaceuticals Limited (SMSPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 34.29B |
| Enterprise Value | 37.48B |
| P/E Ratio | 34.03 |
| PEG Ratio | 0.88 |
| Price/Sales Ratio | 4.07 |
| Price/Book Ratio | 4.48 |
| Enterprise/Revenue | 4.43 |
| Enterprise/EBITDA | 22.18 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.15 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 8.87B |
| Revenue/Share | 97.05 |
| Gross Profit | 1.75B |
| EBITDA | 1.71B |
| Net Income | 1.02B |
| Diluted EPS | 11.15 |
Balance Sheet
| Total Cash | 460.75M |
| Total Cash/Share | 5.04 |
| Total Debt | 3.65B |
| Total Debt/Equity | 0.46 |
| Current Ratio | 1.81 |
| Book Value Per Share | 85.99 |
Price History
| 52-Week Change | 66.27 |
| 52-Week High | 447.8 |
| 52-Week Low | 207.99 |
| Moving Average 50 Days | 394.67 |
| Moving Average 200 Days | 341.08 |
Statistics
| Average Volume | 304,214 |
| Shares Outstanding | 93.65M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 0.1 |
| Payout Ratio | 0.03 |
| Last Split Factor | 10:1 |
| Last Split Date | December 17, 2015 |
AD
